Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-24 @ 1:21 PM
NCT ID:
NCT02067195
Eligibility Criteria:
Inclusion Criteria:
* all consecutive patients with STEMI, age at least 18 years, who were candidates for primary PCI were considered for enrollment.
Exclusion Criteria:
* contrast medium administration within the previous 14 days or follow 72 hours,
* end-stage renal failure or renal transplantation, and refuse PCI or dead during the procedure,
* heart failure of cardiac shock or New York Heart Association class IV,
* recent acute kidney injury defined as an absolute increase of 0.5 mg/dl in serum creatinine over baseline in the past 24h
* ,the presence of lactation, pregnancy,
* malignant tumour or life expectancy less than 1 year,
* allergy to contrast, peri-procedural receipt of metformin non-steroidalanti-inflammatory drugs in the past 48h and during the study period,
* planned renal catheterization or heart valvular surgery。
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02067195
Study Brief:
Protocol Section:
NCT02067195